joshua knighten

San Diego, CA (USA)
Role(s):
Founder/Owner/Principal

Enovadent

Find More Startups Startup
Location: San Diego
Industry: Bio-Technology
Year Founded: 2010
Number Employees: 1-10 people
Business Stage: Growth (not profitable)
Entity Type: "C" Corporation
Description: Executive Summary Enovadent Technologies Enovadent is a new company that provides high quality virtual glasses connected to a centralized online portal for use in medical applications, therapies and consumer markets. Enovadent is scheduled to begin operations immediately upon funding. Enovadent is a California C Corporation registered as Veteran owned. Enovadent is registered and able to accept Federal Grants and Contracts. Several opportunities are currently available for the use of the EnoVision Patient Video System or PVS to; aid in PTSD treatment, assist with learning disabilities, other social and behavioral diseases as well as any visual and audio treatments. Enovadent is poised to begging distribution of the PVS six to eight months after funding. Primary markets are in order; Military, Dental, Hospitals, Medical Clinics (Chemo / Dialysis) and finally all Consumer markets such as Airliners, Transportation and individual consumers. The EnoVision PVS used high-tech virtual glasses that connect to the Enovadent Portal. The portal directs media, therapies and applications to each individual system. Each system has built in bio-feedback that is collected and stored on the portal for analysis from Physicians or used for other applications that analyze and exploit the data. The EnoVision is PVS is fully patented and protected. The law firm representing Enovadent is Wilson Sonsini Goodrich & Rosati (12235 El Camino Real, Suite 200 San Diego, CA 92130) Enovadent profits in four core categories: Note not all categories are used for every market and prices vary according to market. • Unit sales NI $700-2000 per unit • Monthly media fees NI $25-80 per unit • Monthly advertising NI $264-528 per unit • Upgrades and custom software It is estimated that approximately 1 Million PVS will be sold by 5 years, bringing approximately 6 Billion in revenues to Enovadent. Given the number of markets and demand this estimate is extremely conservative.